LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis

NCT00608894 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Study was discontinued due to slow enrollment

Conditions

Autoimmune Hepatitis

Interventions

DRUG: LCP-Tacro (tacrolimus)
DRUG: Azathioprine

Sponsor

Veloxis Pharmaceuticals